Is Stage 1 Hypertension as Defined in ACC/AHA Guidelines Associated with Any Events?

New information has been published fast, and what we thought we knew about hypertension has also changed fast. One of the biggest differences between American and European hypertension guidelines is whether patients with systolic blood pressure (BP) 130/139 mmHg and diastolic BP 80/89 mmHg are considered hypertensive or not. The only place where enough patients with these levels could be found is China and, while a Chinese population is clearly different from a Latin America population, this work answered some of our questions.

¿Es seguro dar el alta el mismo día luego de una angioplastia?The effect of considering these patients as hypertensive as per American guidelines is observed in a reduction of cardiovascular risk among young or middle-aged patients, but no benefit is observed in patients ≥60 years old.

 

This work included 21,441 patients over 35 years old without cardiovascular disease at baseline for this registry. The follow-up was 20 years for the entire cohort and the risk of cardiovascular disease calculated could be attributed to the new stage 1 hypertension classification.


Read also: New European Hypertension Guidelines Contrast with American Recommendations.


The risk of cardiovascular disease for patients from 35 to 59 years old with stage 1 hypertension almost doubled the risk for people with BP <120/80 (hazard ratio [HR] for cardiovascular disease: 1.78; 95% confidence interval [CI]: 1.50 to 2.11). The increase in the specific risk of coronary disease was similar (HR: 1.77; 95% CI: 1.33 to 2.36), while the increase in the risk of stroke was somewhat higher (HR: 1.79; 95% CI: 1.45 to 2.22). The increase in the rate of cardiovascular death was more than double (HR: 2.50; 95% CI: 1.66 to 3.77), which is worrisome.

 

The proportions of cardiovascular death and events attributable to stage 1 hypertension among participants aged 35 to 59 years were 26.5% and 13.4%, respectively.

 

However, among participants aged ≥60 years, no higher risk was observed in patients with stage 1 hypertension compared with those with BP <120/80 mmHg.


Read also: New High Blood Pressure Guidelines.


Over 15 years, 65% of young patients with stage 1 hypertension evolved to 140/90 mmHg or higher, and their risk rates tripled compared with the remaining 35% who maintained a BP lower than 130/80 mmHg.

 

Conclusion

The effect of considering patients with BP between 130/139 and 80/89 mmHg (American College of Cardiology/American Heart Association [ACC/AHA] stage 1 hypertension) as hypertensive is observed only in young and middle-aged patients, while those aged ≥60 years did not evidence any association between these figures and cardiovascular risk.

 

Original title: Long-Term Cardiovascular Risk Associated with Stage 1 Hypertension Defined by the 2017 ACC/AHA Hypertension Guideline.

Reference: Yue Qi et al. J Am Coll Cardiol 2018;72:1201-10.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

How real are the adverse effects of statins? Evidence from randomized clinical trials

The safety of statins continues to be a subject of debate, partly due to the extensive list of adverse effects included in prescribing information,...

Is it safe to use negative chronotropic drugs early after TAVI?

TAVI is associated with a relevant incidence of conduction system disturbances and the development of atrioventricular block that may require permanent pacemaker implantation. Many...

Dual Antiplatelet Therapy in Diabetic Patients with AMI: De-Escalation Strategy

Diabetes Mellitus (DM) is a common comorbidity in patients hospitalized for acute coronary syndrome (ACS) of increasing prevalence over the last decade, associated with...

AHA 2025 | OPTIMA-AF: 1 Month vs. 12 Months of Dual Therapy (DOAC + P2Y12) After PCI in Atrial Fibrillation

Concomitant atrial fibrillation (AF) and coronary artery disease is a common occurrence in clinical practice. In these patients, current guidelines recommend 1 month of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

Can Coronary CT Angiography Replace Invasive Coronary Angiography in Pre-TAVI Coronary Assessment?

Coronary artery disease coexists in approximately half of patients undergoing transcatheter aortic valve implantation, making coronary assessment prior to the procedure essential. Invasive coronary...